Best Shares to Buy Now – April 2021

In this edition of our monthly stock market analysis, we are going to look at the best shares to buy in April 2021 – with our analysis covering April 13th to April 19th.

Top 5 Shares to Buy Right Now

Before we take a closer look at April’s best shares, here are our top 5 picks:

  1. Coinbase
  2. Pfizer
  3. Amazon
  4. Moderna
  5. Paypoint

You can buy all of these top shares, as well as many others, at eToro and pay 0% fees!

1. Coinbase – Bitcoin Jumps to Record Highs as Coinbase gets ready for $100bn IPO (HOLD)

April 13th – April 19th: Since going public on the NASDAQ stock exchange last Wednesday, Coinbase shares have shot up to over $320 per share. If you got in on the IPO, continue to hold. If you missed it, it might be a good idea to wait and see what happens to the stock price over the next few weeks.

Coinbase is a top-rated and trusted online platform for anything to do with digital currencies, from trading, transferring and storing cryptos, Coinbase has you covered.

Coinbase

Market analysts are primed and ready for the Coinbase IPO to hit the NASDAQ exchange with many regarding it as a potential watershed moment for the online cryptocurrency sector.

Reacting to the landmark event, the price of Bitcoin surged to $62,747.90. The NASDAQ has forecast the price of each share at $250 which would mean that Coinbase would have a market cap of about $47bn.

Just last month Coinbase shares were traded as private stock with a market valuation of about $90bn. This has sparked speculations that Coinbase’s IPO debut may reach a value of $100bn, which would make it the biggest direct listing in history.

With the Nasdaq forecasting Coinbase shares at $250 a piece, this is definitely the most promising and exciting news this month!

2. Pfizer – COVID-19 Vaccine Approved in Several Countries (HOLD)

April 13th – April 19th: Pfizer shares had a good week as the Johnson & Johnson vaccine pause in the US continued and the US Food and Drug Administration looked into expanding eligibility for the Pfizer vaccine to kids aged 12-15. The shares are up 5.4% to $39.18 apiece.

Pfizer is one of the first companies to widely distribute a COVID-19 vaccine, along with Moderna. In November, the company announced that its vaccine was over 90% effective.

Pfizer already has commitments from various governments for over 450 million doses. By the end of 2021, the company says it could produce as many as 1.3 billion doses globally.

New variants of the coronavirus are proving somewhat resistant to Pfizer’s vaccine, which is driving concerns that the company’s treatment won’t be as widely used as previously thought. But Pfizer can relatively easily develop a variant-specific booster shot, and the company’s original vaccine is moderately effective against all current strains of COVID-19.

If the vaccine isn’t reason enough for you to like Pfizer shares, the company offers a very attractive 4.35% dividend yield.

3. Amazon – Unbeatable Returns in 2021 (HOLD)

April 13th – April 19th: Amazon shares dropped 2.0% this week as it continues to trade in a range around the $3,300 level. If Amazon shares can break above $3,500 in the next few weeks, look for a sustained upward price movement to follow.

Amazon boasted massive gains in the first half of 2020 as the COVID-19 pandemic gripped the world. The shares started last year at less than $1,900 each, and finished the year at over $3,250 each.

Along the way, Amazon solidified its dominance in global eCommerce and made itself an essential part of global infrastructure. Not only is its core online retail business growing year-on-year, but it is involved in heaps of other innovative products and services. This includes its ever-growing Amazon Prime subscription model, as well as cutting-edge technologies like cloud computing and artificial intelligence.

We don’t see Amazon slowing down any time soon, so it’s among our top picks in 2021.

4. Moderna – mRNA Vaccine Pioneer (HOLD)

April 13th – April 19th: Moderna shares had a strong week, gaining more than 11% to $171 per share. Investors appear to be reacting to the troubles that Johnson & Johnson and AstraZeneca have had with their COVID-19 vaccines, so the bounce might be short-lived. But either way, we’re happy to see Moderna shares continuing the recent run of bullish momentum. 

Moderna was right behind Pfizer in getting its COVID-19 vaccine out into the world, and it’s now reached parity in terms of distribution and pending orders. The company’s vaccine is somewhat less effective at preventing disease from new coronavirus variants, but the company is working on a booster that will specifically target these variants.

Like Pfizer, Moderna is also using mRNA technology that could fundamentally change the way the world approaches vaccination in the future. What’s especially exciting about Moderna is that the company has set its sights beyond the coronavirus pandemic. Moderna is already developing five vaccine candidates, five immuno-oncology candidates, four rare disease therapies, and two autoimmune disease inhibitors. While none of these treatments are proven, the fact that Moderna’s COVID-19 mRNA vaccine is effective bodes extremely well.

To be sure, the company is expensive. But it’s never going to be cheaper than it is now once mRNA technology gains widespread traction.

5. Paypoint- Super-Undervalued Stock Ready to Bounce-Back After Lockdown (HOLD)

paypoint sharesApril 13th – April 19th: Paypoint shares gained another 2.1% this week, building on its strong gains from the week before. The shares are now encountering a resistance level around 630p, so we’ll be keeping a close eye on whether the shares can break out over the coming week. 

Paypoint is the tech company behind the in-store payment services found in tens of thousands of UK locations.

This includes everything from retail and convenience stores, supermarkets, and petrol stations. The shares are listed on the London Stock Exchange with a current market capitalization of just £414 million. Make no mistake about it, Paypoint shares have been hammered this year as a result of the wider COV19 lockdowns.

This makes sense when you consider that the vast majority of its retail locations have been closed for months on end. In fact, with the stocks valued at over 1000p at the start of the year, Paypoint shares are now 40% at 600p. But, this exciting technology company was looking good before the virus came to fruition.

As such, there is no reason to believe that it will not get back to pre-COV19 levels when the lockdown restrictions are just a distant memory. If the shares do breach the 1000p-level, this would require an increase of over 65% based on current prices.

6. Apple – Superb Earnings Report (HOLD)

April 13th – April 19th: Apple shares gained 2.2% this week, riding the broader surge in tech stocks over the past week. Still, Apple stock has been trading in a relatively narrow range for months, as investors wait to see what’s next for the tech giant in the wake of the pandemic. 

Despite initial concerns that demand for Apple’s consumer-centric tech products would fade in light of the COVID-19 pandemic, the company had a blowout 2020. In its most recent earnings report, Apple reported that there are now over 1 billion iPhones in the world and it smashed its own records for annual sales.

Apple continues to boost its bottom line, too. The company announced last year that it will start making its own chips for Mac computers, which could boost the company’s desktops and laptops after years of relative neglect. Apple is also looking for ways to take advantage of the shift to 5G, or to offer services for electric and self-driving vehicles.

We’re very bullish about Apple, as are most analysts. Anytime the shares pull back, consider loading up on more.

7. Tesla – Catch This Growing Company While You Still Can (HOLD)

April 13th – April 19th: Tesla gained 5.4% this week, a bullish sign for the company after its pullback in March. Still, Tesla shares remain well below the all-time high of $900 reached earlier in the year, so we’re looking forward to more gains from this electric car maker.

Tesla was long the butt of jokes on Wall Street, but the company has proved all of the experts wrong. Last year, the shares gained an incredibly 743% and nearly every major trading firm upgraded its outlook for Tesla.

Right now, the company is running away with the electric vehicle market and seemingly winning the race for self-driving vehicles. It also owns Solar City, a solar panel installer, so it’s extremely well poised to ride the wave of pro-green energy sentiment sweeping the US right now.

Tesla delivered half a million cars last year, which isn’t much. But that represented a huge milestone for the company, and it’s a sign that Tesla is ramping up production very quickly. Look to see Tesla cars on every road in the years ahead – and Tesla stock to be flying high.

8. Easyjet – At Current Prices This Stock is Too Cheap to Turn Down (Hold)

April 13th – April 19th: Easyjet shares jumped 6.4% in another volatile week for this airline stock. Although the shares have been up and down in recent weeks, it’s holding steady at a higher level than it held in February. There’s still a very long way for Easyjet shares to go before getting back to pre-pandemic levels of 1,500p, so it remains a strong hold.   

We don’t need to tell you that airline stocks have been hit especially hard over the past 12 months. Crucially, global travel restrictions remain in place across most regions – so passenger numbers are still at just a fraction of pre-pandemic levels.

In turn, not only have the value of airline stocks nosedived over the past year but the risks of investing have never been higher. With that being said, if you have a slightly higher appetite for risk and you are looking to target larger financial returns, Easyjet looks like the best pick of a bunch from the airline scene.

First and foremost, at current prices of 803p per share, the upside potential is huge. If we were to take the pre-pandemic price of 1,500p as the medium-to-long term target, this would require an upward movement of 86%. Secondly, it is important to remember that Easyjet share saw growth of 60% in the 7 months before airline stocks capitulated. This means that the firm was enjoying a successful period of activity – interrupted only by the wider impact of global travel restrictions.

On the other hand, much like any other airline stock, Easyjet shares are far from guaranteed to get back to pre-COVID levels. After all, it’s burning through cash at a rapid rate and in November 2020, reported a huge loss of £1.3 billion. The good news for concerned stockholders is that the airline has since secured over £3 billion in liquidity. It is hoped that this will be sufficient to see Easyjet throughout these turbulent times.

9. Cineworld – Vaccine Approval is Huge New for This Cheap Stock (Hold)

cineworld sharesApril 13th – April 19th: Cineworld shares traded flat this week, which is a welcome respite after the stock’s recent volatility. We believe the cinema chain is likely to continue to see strong performance as the coronavirus vaccine rollout continues and consumers get ready for a slate of summer movie premieres.

If you’ve been keeping track of our weekly stock market analysis for some time now, then you’ll know that Cineworld Group is in and out of our portfolio like a yo-yo.

Crucially, this is because of the UK’s lockdown strategy that has changed consistently over the past 6 months. With that said, the Pfizer vaccine approval means that Cineworld cinemas will once again reopen its doors. When remains to be seen – but it is no longer a case of ‘if’.

Now, it is no secret that Cineworld was heavily impacted by the pandemic shutdown, and thus – its shares have completely capitulated in 2020.

Starting off 2020 at 220p each, Cineworld shares have since hit lows of just 15p. This translates into a stock price decline of 93% – meaning a £1,000 investment would have left you with just £70. Crucially, the vaccine approval now means that the shares are back on the up – and quickly.

The shares are now trading at 78p. At this price level, you can still get yourself a huge bargain – especially considering the 220p valuation the shares held just 11 months ago. If Cineworld is able to get back to pre-pandemic levels, this would require growth of 185%.

10. Facebook – No Dividends, but Huge Upside Potential (HOLD)

April 13th – April 19th: Facebook shares dropped from $311 to $306 this week, indicating that the stock might retest its support/resistance level at $300 in the coming weeks. If it can stay above $300 when that test comes, look for Facebook to continue its long-term bullish momentum.  

Although you have missed the boat on Facebook – at least in terms of its initial stock market price – it’s still not too late to obtain its shares at an attractive price.

The company has grown to exponential heights since its public launch in 2013 – and while the social media giant has had its fair share of privacy-related scandals, the future looks bright.  Crucially, Facebook now boasts an impressive 2.6 billion monthly active users – which is up 11% from the prior 12 months.

With this in mind, its current market capitalization of $735 billion is potentially still just a fraction of what it could be worth in years to come. On the flip side, Facebook is yet to pay any dividends to shareholders, but this could something the company looks at in the near future.

Get Free Stock Tips to Your Inbox Now

  • What Stocks Should You Invest In?
  • Discover how to find winning stocks
  • Receive weekly stock tips from the Pros
Get Access Now

Best Shares April 13th – April 19th Update

All of the major US and UK indices were in the green this week as bulls took firm control of the stock market. In fact, the Dow Jones closed above the 34,000 level for the first time ever on Thursday, and all indices ended the week on a positive note on Friday. With the global economic outlook improving every day and the vaccination campaign continuing apace in the US and UK, we could be in for more bullish market activity in the week ahead.

Let’s recap how the markets have performed over the past week.

  • FTSE 100: +1.89%
  • FTSE AIM All-Share Index: +1.58%
  • S&P 500: +1.39%
  • NASDAQ 100: +1.61%
  • Dow Jones: +1.35%

Shares to Watch – April 12th – April 19th

The following shares didn’t quite make the cut this week – but are most definitely worth keeping an eye on over the next 7 days.

  • Etsy: Etsy has experienced explosive growth over the past year, but the shares have been highly volatile in recent weeks. This could be a good chance to pick up shares at a discount before the stock’s momentum picks up again.
  • Johnson & Johnson: This COVID-19 vaccine maker has been trending strongly upwards since October. The stock has lost significant ground in recent weeks due to manufacturing issues and the pause on distribution over fears that the vaccine could cause blood clots in some people. We see this pullback as a potential opportunity to buy. The Johnson & Johnson vaccine is one of the first one-shot vaccines developed for COVID-19 and as manufacturing capacity ramps up, the shot could be the prime weapon against COVID-19 around the world.
  • American Express: This major US stock has been climbing steadily in recent months, so it has strong potential as a momentum trade. American Express could particularly benefit as consumers begin to spend money again in the US this summer.

While there are many different types of shares out there, there are also thousands of different company shares from around the world that you can invest in. Different shares of companies come in all shapes and sizes, so it’s important to do your research and ensure you invest in the companies that best match your portfolio. Let’s take a look at some of the most popular companies to invest in in the UK.

Comprehensive List of the Best Shares

We’ve already covered the top 10 shares to invest in right now, but there are many more worth considering. Check out our comprehensive list of the best shares below

How to Buy the Best Shares Now

If you want to buy shares in one of the companies listed above, you will need to use an online stock broker. In this respect, most newbie investors consider eToro for the following reasons:

  • You can buy shares without paying a single penny in commissions
  • You can buy shares from just $50 (about £40) per trade
  • You can easily deposit funds with a debit/credit card, UK bank account, or e-wallet
  • The platform is tailored to those with little to no experience of buying shares online
  • The platform is regulated by the FCA

Here what you need to do to buy shares from eToro:

Step 1: Open an Account

First and foremost, head over to the eToro website and elect to open an account. You will now be asked to enter some personal information – such as your full name, home address, date of birth, and contact details, You’ll also need to choose a username and a strong password.

Step 2: Upload ID

On top of the Financial Conduct Authority (FCA), eToro is also regulated by ASIC (Australia) and CySEC (Cyprus). As such, it is required to identify each and every user that opens an account. All you need to do is upload a copy of your UK passport or driver’s license, followed by a utility bill or bank account statement.

Step 3: Deposit Funds

You will now be asked to deposit some funds. eToro accepts a variety of UK payment methods, including:

  • Debit Card
  • Credit Card
  • UK Bank Transfer
  • Paypal
  • Skrill
  • Neteller

You will need to meet a minimum deposit amount of $200 (about £160). Your GBP deposit will be converted to USD (0.5% conversion fee), as this allows you to access both UK and international markets at the click of a button.

Step 4: Buy Shares

Once your account has been funded, you can then buy your chosen shares. If you know which of the above companies you wish to buy shares in, simply enter it into the search box at the top of the screen, and then click on the ‘TRADE’ button. In our example, we are looking to buy BP shares.

You will then see an order box that asks you to enter the amount that you wish to buy. This is in US dollars and not the number of individual shares. As we noted earlier, you can buy from just $50 (£40) worth of shares at eToro, so there is no requirement to buy a whole stock.

Finally, click on the ‘OPEN TRADE’ button to complete the share investment process!

How to Analyse Which Shares to Buy

If you are just starting out in the world of stocks and shares, it’s super-important that you learn the ins and outs of how to perform your own research – as opposed to choosing companies on the back of somebody else’s advice. In doing so, you stand the best chance possible of ascertaining whether or not the shares represent a viable long-term investment.

You can read more on How to Pick Stocks and Shares here.

Best Shares to Buy Today – The Verdict?

As you’ll see from our list of the best shares to buy in March 2021 – most of our portfolio consists of US stocks. This is for good reason – with the likes of Pfizer, Moderna, Tesla, Apple, and Amazon smashing through the uncertainties of the coronavirus pandemic.

Over in the UK, very few FTSE 100 shares are worth more than pre-pandemic levels. In fact, the FTSE 100 Index itself is still down for the year. Nevertheless, we are still super-keen on British American Tobacco for its strong and stable characteristics. We are also keen on Cineworld for its long-term value – as per the Pfizer vaccine approval announced in the UK.

The latest UK addition to our portfolio is that of Easyjet. Sure, the wider airline industry is fraught with risk at present. But, at current prices, Easyjet looks too cheap to turn down.

If you want to invest in the best shares to buy today, there’s no better place to do so than eToro. Simply click the link below to sign up today!

eToro – Buy the Best Shares With No Commission

 

67% of retail investor accounts lose money when trading CFDs with this provider.

Kane Pepi

About Kane Pepi PRO INVESTOR

Kane Pepi is a British researcher and writer that specializes in finance, financial crime, and blockchain technology. Now based in Malta, Kane writes for a number of platforms in the online domain. In particular, Kane is skilled at explaining complex financial subjects in a user-friendly manner. Academically, Kane holds a Bachelor’s Degree in Finance, a Master’s Degree in Financial Crime, and he is currently engaged in a Doctorate Degree researching the money laundering threats of the blockchain economy. Kane is also behind peer-reviewed publications - which includes an in-depth study into the relationship between money laundering and UK bookmakers. You will also find Kane’s material at websites such as MoneyCheck, the Motley Fool, InsideBitcoins, Blockonomi, Learnbonds, and the Malta Association of Compliance Officers.

Questions & Answers (0)

Have a question? Our panel of experts willanswer your queries.Post your question

Leave a Comment

Your email address will not be published. Required fields are marked *